VIR Q4 2020 8-K

Company

Vir Biotechnology, Inc.

Filed

February 25, 2021

Period of Report

February 25, 2021

Accession Number

0001564590-21-008847

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →